Foresight Institute Radio

What are the best strategies for addressing extreme risks from artificial superintelligence? In this 4-hour conversation, decision theorist Eliezer Yudkowsky and computer scientist Mark Miller discuss their cruxes for disagreement.

They examine the future of AI, existential risk, and whether alignment is even possible. Topics include AI risk scenarios, coalition dynamics, secure systems like seL4, hardware exploits like Rowhammer, molecular engineering with AlphaFold, and historical analogies like nuclear arms control. They explore superintelligence governance, multipolar vs singleton futures, and the philosophical challenges of trust, verification, and control in a post-AGI world.

Moderated by Christine Peterson, the discussion seeks the least risky strategy for reaching a preferred state amid superintelligent AI risks. Yudkowsky warns of catastrophic outcomes if AGI is not controlled, while Miller advocates decentralizing power and preserving human institutions as AI evolves.

The conversation spans AI collaboration, secure operating frameworks, cryptographic separation, and lessons from nuclear non-proliferation. Despite their differences, both aim for a future where AI benefits humanity without posing existential threats.

This is a teaser episode of the Existential Hope Podcast with Nobel Laureate David Baker. David reveals how scientists are now inventing entirely new proteins—life's fundamental building blocks—to tackle some of the world's most pressing challenges.

David shares his journey and his vision for a future where custom-built "molecular machines," an idea once explored by thinkers like Eric Drexler, could repair our bodies, clean up pollution, and create sustainable materials. He explains how breakthroughs in AI are supercharging this field, but also why human ingenuity and collaborative science are still essential to unlocking these revolutionary possibilities.

In this conversation, we explore:

• The incredible power of designing brand-new proteins for groundbreaking medicines, environmental cleanup, and creating novel materials.
• The exciting prospect of "molecular machines": tiny engines built from proteins to perform complex tasks, inspired by early visions of nanotechnology.
• How AI is accelerating scientific discovery, and what it takes to translate these digital designs into real-world solutions.
• David’s "communal brain" philosophy for fostering innovation and his advice for anyone wanting to solve big, meaningful problems.

This feed is now Foresight Institute Radio—your place for standout talks on frontier technology: from AI and neurotech to nanotech, longevity, and space. You’ll hear highlights from Foresight’s global conferences and seminars featuring top scientists and builders.

For long-form interviews, follow our sister show: The Existential Hope Podcast, with guests like David Baker, Steven Pinker, and David Deutsch.

Want the slides? Subscribe on YouTube and follow us on X @ForesightInst.

🎤 Featuring: Allison Duettmann, CEO of Foresight Institute

What happens when parents can choose their children's genetic traits, and which selections benefit society versus harm it? In this talk, Jonathan Anomaly explores the emerging field of embryo selection for intelligence, disease prevention, and longevity. He covers how polygenic risk scores work to predict complex traits and why most diseases involve thousands of genetic variants rather than single genes.

Jonathan Anomaly is a former professor who spent 15 years studying the intersection of game theory and ethics, focusing on collective action problems. He recently co-founded a stealth company that will be among the first to offer embryo selection for intelligence and disease prevention.

This talk was recorded at Vision Weekend Puerto Rico 2025. To see the slides and more talks from the event, please visit our Youtube channel.

What if you could diagnose stroke, treat cancer, and cure depression with a smartphone-sized device that costs $1,000 instead of millions? In this talk, Mary Lou Jepsen demonstrates her revolutionary handheld medical devices that use ultrasound and infrared light to selectively target diseased cells while leaving healthy tissue unharmed. She covers how her team achieved 100% remission in deadly glioblastoma cancer in mice, moved nearly half of treatment-resistant depression patients into remission, and why making all 68 patents open source could democratize healthcare globally while reducing medical device costs by 93%.

Mary Lou Jepsen is a serial hardtech entrepreneur and former MIT professor with a PhD in physics from Brown University. She previously founded multiple multi-billion dollar companies, left Facebook to start her current venture, and recently raised $54 million to bring these breakthrough medical technologies to market as open-source solutions.

This talk was recorded at Vision Weekend US 2024. To see the slides and more talks from the event, please visit our Youtube channel.